ESR1 and breast carcinoma: Although both cell lines are ER+luminal breast cancer cell lines, a key difference between them at the molecularlevel is that MCF7 cells express WT p53, whereas T47D cells carry aTP53 missense mutation (nonfunctional p53) (Schafer et al., 2000).